The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib trial of belvarafenib in combination with cobimetinib in patients with advanced solid tumors: Interim results of dose-escalation and patients with NRAS-mutant melanoma of dose-expansion.
 
Sang Joon Shin
No Relationships to Disclose
 
Jeeyun Lee
Consulting or Advisory Role - Mirati Therapeutics; Oncologie
Research Funding - AstraZeneca; Lilly; Merck Sharp & Dohme
 
Tae Min Kim
Consulting or Advisory Role - BeyondBIO; GI CELL; Hanmi
Speakers' Bureau - Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Bayer; Boryung; Novartis; Roche/Genentech; Sanofi
 
Jin-Soo Kim
Stock and Other Ownership Interests - DAEHWA Pharmaceutical
Honoraria - AstraZeneca; Boehringer Ingelheim; CJ Healthcare; DAEHWA Pharmaceutical; Lilly; Merck
Consulting or Advisory Role - CJ Healthcare; Lilly
Research Funding - Alpha Biopharma; ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Chong Kun Dang Pharmaceutical; CJ Healthcare; Hanmi; IL-Yang Pharm; Lilly; Merck; MSD; Novotech; Ono Pharmaceutical; Pfizer; Sanofi; Yuhan
Expert Testimony - CJ Healthcare
 
Yu Jung Kim
No Relationships to Disclose
 
Yong Sang Hong
No Relationships to Disclose
 
Sun Young Kim
Research Funding - Roche/Genentech (Inst)
 
Jeong Eun Kim
No Relationships to Disclose
 
Dae Ho Lee
Honoraria - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Chong Kun Dang Pharmaceutical; CJ Healthcare; Green Cross; Janssen; Lilly; Menarini; Merck; MSD; Mundipharma; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech; Samyang; ST Cube; Takeda
Consulting or Advisory Role - ST Cube
Travel, Accommodations, Expenses - Blueprint Medicines; Takeda
 
Yoon-hee Hong
Employment - Hanmi
Patents, Royalties, Other Intellectual Property - Patent - Belvarafenib for use in cancer treatment
 
Young Su Noh
Employment - Hanmi
 
Song Kim
Employment - Hanmi
 
Eunhye Baek
Employment - Hanmi
 
SuJin Jung
No Relationships to Disclose
 
Paul Rhee
Employment - Hanmi
 
Jinjoo Kim
No Relationships to Disclose
 
Jennifer Eng-Wong
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Vikram Malhi
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Sharareh Monemi
Employment - Genentech; Genentech
Leadership - Genentech/Roche; Genentech/Roche
Stock and Other Ownership Interests - Genentech
Honoraria - Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - AstraZeneca (Inst); Sanofi (Inst)